Navigation Links
Watson Second Quarter 2011 Net Revenue Exceeds $1 Billion; Non-GAAP EPS of $1.01
Date:7/26/2011

27.6)(33.9)(49.0)(54.2)Non-GAAP net income attributable to
 common shareholders

$
27.9$
2.8$
239.8$
203.1Diluted earnings per share Diluted earnings per share - GAAP

$
.42$
.57$
.78$
.14Diluted earnings per share - Non-GAAP

$
.01$
.83$
.90$
.64Basic weighted average common shares outstanding

124.5122.3124.1122.0Effect of dilutive securities:   Dilutive share-based compensation arrangements

1.91.72.01.7Diluted weighted average common shares outstanding

126.4124.0126.1123.7(1)  Includes accelerated depreciation charges.   The following table presents a reconciliation of reported net income to adjusted EBITDA for the three and six months ended June 30, 2011 and 2010:

Table 5Watson Pharmaceuticals, Inc.Adjusted EBITDA Reconciliation Table(Unaudited; in millions)Three Months EndedJune 30,Six Months EndedJune 30,2011201020112010GAAP net income attributable to common shareholders$
52.7$
70.6$
98.0$
40.4Plus:Interest expense22.920.044.740.3Interest income(0.5)(0.3)(1.3)(0.7)Provision for income taxes43.227.984.564.6Depreciation (includes accelerated depreciation)25.726.648.751.3Amortization74.943.1132.082.1EBITDA218.9187.9406.6378.0Adjusted for:Global supply chain initiative2.012.78.516.5Acquisition and licensing charges8.72.113.321.5Non-cash impairment charges7.40.121.81.1Other (gains) losses(1.5)(1.4)(7.2)(24.8)Legal settlements---3.0Share-based compensation7.86.016.211.0Adjusted EBITDA$
243.3$
207.4$
459.2$
406.3The following table presents a reconciliation of forecasted net income for the twelve months ending December 31, 2011 to non-GAAP net income and non-GAAP earnings per diluted share:

Table 6Watson Pharmaceuticals, Inc.Reconciliation Table (Unaudited; in millions except per share amounts)Forecast for Twelve MonthsEnding December 31, 2011LowHighGAAP to non-GAAP net income calculationGAAP net income

$
226$
25
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Watson Confirms JALYN™ Patent Challenge
2. Watson Confirms Favorable Appeals Court Decision in Mucinex(R) Patent Suit
3. Watson Confirms Vyvanse® Patent Challenge
4. Watson to Host Conference Call and Webcast to Discuss Second Quarter 2011 Earnings
5. Watson Announces Expansion of Salt Lake City, Utah Pharmaceutical R&D and Manufacturing Facility
6. Watson to Present at 2011 Wells Fargo Securities Healthcare Conference
7. Watson Confirms AVODART(R) Patent Challenge
8. Watson Confirms Court Decision Rejecting Tevas Motion to Prevent Launch of Generic SEASONIQUE®
9. Watsons Nabumetone Tablets Receive FDA Approval
10. Watson Confirms Pataday™ Patent Challenge
11. Watson Confirms Viagra® Patent Challenge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 31, 2014  Grammy Award-winner Bruce Hornsby ... of philanthropists, athletes, actors, and musicians during the 10 ... 19 at the Mandarin Oriental Hotel in ... will honor six individuals who embody the values of ... bestow its highest honor, the Spirit of an Active ...
(Date:10/31/2014)... Oct. 31, 2014 Mast Therapeutics, Inc. (NYSE ... results for the quarter ended September 30, 2014. ... Officer, said:  "The third quarter was productive for Mast. Consistent ... of MST-188 for sickle cell disease is on track ... now have opened 50 study sites in the U.S. ...
(Date:10/31/2014)... 2014 Imago BioSciences, Inc., a biotech ... million Series A financing led by Clarus Ventures ... team of accomplished investment and operating professionals dedicated ... round include Frazier Healthcare, Amgen Ventures, and Merck ... and Frazier Healthcare will join the company,s board ...
Breaking Medicine Technology:10th Anniversary Orthopaedic Foundation Gala Set For Success 2Mast Therapeutics Reports Third Quarter 2014 Financial Results 2Mast Therapeutics Reports Third Quarter 2014 Financial Results 3Mast Therapeutics Reports Third Quarter 2014 Financial Results 4Mast Therapeutics Reports Third Quarter 2014 Financial Results 5Mast Therapeutics Reports Third Quarter 2014 Financial Results 6Mast Therapeutics Reports Third Quarter 2014 Financial Results 7Mast Therapeutics Reports Third Quarter 2014 Financial Results 8Imago BioSciences Announces $26.5 Million Financing Led by Clarus Ventures 2
... Boston Scientific Corporation (NYSE: BSX ) today announced ... Johnson & Johnson, including the Palmaz-NIR suit. All ... arena. In connection with the settlement, Boston Scientific ... & Johnson. The settlement payment is within Boston ...
... MUMBAI, India, Sept. 29 Pharmaceutical Major, Lupin Ltd. announced ... 43 mg and 130 mg). Lupin acquired the product ... of the U.S. Bankruptcy Court. Antara recorded net sales ... 2008). Lupin paid $ 38.61 million for the product ...
Cached Medicine Technology:Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes 2Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes 3Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes 4Lupin Expands Branded Play 2Lupin Expands Branded Play 3
(Date:10/31/2014)... HealthDay Reporter THURSDAY, Oct. 30, ... organ transplantation is nothing new. The first kidney transplant ... in 1963 and the first human heart transplant in 1967. ... patient,s entire face. One major organ still eludes the ... team of U.S. scientists has its way, that dream may ...
(Date:10/31/2014)... News) -- Each year, people across the United States ... relatives and friends, which costs $522 billion, according to ... price tag on the time and wages that caregivers ... need assistance in daily activities. The study authors said ... interest in workplace flexibility policies. "Our findings provide ...
(Date:10/30/2014)... Einstein College of Medicine of Yeshiva ... their latest aging research at the Gerontological Society ... include the identification of a genotype that can ... the cellular biology of aging. GSA 2014 will ... "Einstein-Montefiore has distinguished itself in a range of ...
(Date:10/30/2014)... the DFG Research Center for Regenerative Therapies Dresden - ... for the first time the in vitro growth of ... mouse embryonic stem cells. Correct spatial organization of motor ... was observed., This study has been published online by ... on 30.10.2014 ., For many years Elly Tanaka and ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Graphics, coding, ... are synonymous with the craft of web design and ... website. Yet a simpler solution to create a website ... pictures, videos, contact information, customer reviews and Facebook posts ... "It is the next evolution of how a ...
Breaking Medicine News(10 mins):Health News:Scientists Set Their Sights on First Whole-Eye Transplant 2Health News:Scientists Set Their Sights on First Whole-Eye Transplant 3Health News:'Informal Care' for Older Americans Tops $500B Annually, Study Finds 2Health News:Einstein-Montefiore investigators present aging research at Gerontological Society of America's Annual Scientific Meeting 2Health News:Einstein-Montefiore investigators present aging research at Gerontological Society of America's Annual Scientific Meeting 3Health News:Einstein-Montefiore investigators present aging research at Gerontological Society of America's Annual Scientific Meeting 4Health News:Reconstruction of a patterned piece of spinal cord in 3-D culture 2Health News:Facebook Websites In Thirty-Seconds 2
... Residents to Eat Right, Move More and ... Milk Their Diets, ST. ... and downs of different fad diets -- which seem to go in and ... out of three Americans -- including twenty-five percent of St.,Louis residents -- remain ...
... The Blue Cross Blue Shield of Michigan,Foundation has won ... Program. The awards, given by the Council on Foundations ... awareness of foundations and corporate giving programs. The,awards will ... Council on,Foundations on Monday, May 5, 2008 in Maryland., ...
... National Academy of Sciences of the United States has ... a member of this prestigious organization of scientists and ... in recognition of his distinguished and continuing achievements in ... has had a key role in a range of ...
... Universitys Lane Center for Computational Biology have discovered ... an automated method for analyzing cell cultures and ... online in the Journal of Machine Learning Research, ... analysis of the microscopic images produced by todays ...
... aims to educate patients on best ways to get condition ... Have asthma or think you might? Then May is the ... breathing disease. , Free asthma screenings are scheduled to be ... of National Asthma and Allergy Awareness Month. The American College ...
... - LMS Medical Systems (TSX: LMZ,AMEX: LMZ), a ... safety software system for obstetrics, today announced that ... the Company,s common,shares from Amex., The decision ... to,streamline operations and control costs in order to ...
Cached Medicine News:Health News:Message to St. Louis, MO Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to St. Louis, MO Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Message to St. Louis, MO Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 4Health News:Blue Cross Blue Shield of Michigan Foundation Wins Three National Awards for Communications Excellence from Council on Foundations 2Health News:US honor for professor Jerry Adams 2Health News:Carnegie Mellon technique accelerates biological image analysis 2Health News:Free Asthma Screenings Offered in May 2Health News:LMS to delist from Amex 2
Hydrophobic PE filter without self-sealing additives, permits sample recovery after accidental over-pipetting. All filters are sterile (to USP, DAB, Ph.Eur. standards) and PCR clean (free from human ...
... Finntip Filters are ideal for ... or for any work where ... are designed for pipetting DNA/RNA ... and other. For applications requiring ...
Hydrophobic PE filter without self-sealing additives, permits sample recovery after accidental over-pipetting. All filters are sterile (to USP, DAB, Ph.Eur. standards) and PCR clean (free from human ...
Hydrophobic PE filter without self-sealing additives, permits sample recovery after accidental over-pipetting. All filters are sterile (to USP, DAB, Ph.Eur. standards) and PCR clean (free from human ...
Medicine Products: